Cell transformation assays as predictors of human carcinogenicity: The report and recommendations of ECVAM Workshop 39

ATLA Alternatives to Laboratory Animals

Volumn 27, Issue 5, 1999, Pages 745-767

  Combes, Robert ^a,b   Balls, Michael ^b   Curren, Rodger ^c   Fischbach, Michel ^d   Fusenig, Norbert ^e   Kirkland, David ^f   Lasne, Claude ^g   Landolph, Joseph ^h   LeBoeuf, Robert ⁱ   Marquardt, Hans ^j   McCormick, Justin ^k   Müller, Lutz ^l   Rivedal, Edgar ^m   Sabbioni, Enrico ^b   Tanaka, Noriho ⁿ   Vasseur, Paule ^o   Yamasaki, Hiroshi ^p  

^a RUSSELL AND BURCH HOUSE   (United Kingdom)

^b JOINT RESEARCH CENTRE   (Italy)

^c Institute for in Vitro Sciences   (United States)

^d German Cancer Research Centre ^*  (Italy)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f Department of Genetic and Molecular Toxicology   (United Kingdom)

^g Min Land Country Plan and Environ   (France)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ PROCTER AND GAMBLE COMPANY   (United States)

^j University Medical School Hamburg Eppendorf   (Germany)

^k MICHIGAN STATE UNIVERSITY   (United States)

^l Federal Institute for Drugs and Medical Devices   (Germany)

^m OSLO UNIVERSITY HOSPITAL   (Norway)

ⁿ HATANO RESEARCH INSTITUTE   (Japan)

^o Ctr des Sciences de l'Environnement   (France)

^p INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BIOASSAY; CANCER GENETICS; CANCER SCREENING; CARCINOGENICITY; CELL IMMORTALIZATION; CELL TRANSFORMATION; GENOTOXICITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0032716592     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119299902700505     Document Type: Article

References (87)

1. Anon. (1994). ECVAM News & Views. ATLA 22, 7-11.
2. Maronpot, R.R. (1991). Chemical carcinogenesis. In Handbook of Toxicologic Pathology, pp. 91-129. New York, USA: Academic Press.
3. Barrett, J.C. (1993). Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environmental Health Perspectives 100, 9-20.
4. Combes, R.D. (1997). Detection of non-genotoxic carcinogens: major barriers to replacement of the rodent assay. In Animal Alternatives, Welfare and Ethics (ed. L.F.M. van Zutphen & M. Balls), pp. 627-634. Amsterdam, The Netherlands: Elsevier.
5. Berwald, Y. & Sachs, L. (1965). In vitro transformation of normal cells to tumour cells by carcinogenic hydrocarbons. Journal of the National Cancer Institute 35, 641-661.
6. Meyer, A.L. (1983). In vitro transformation assays for chemical carcinogens. Mutation Research 115, 323-338.
7. Barrett, J.C. & Fletcher, W.F. (1987). Cellular and molecular mechanisms of multi-step carcinogenesis in cell culture models. In Mechanisms of Environmental Carcinogenesis, Vol. 2, Multistep Models of Carcinogenesis, pp. 73-116. Boca Raton, FL, USA: CRC Press.
8. Yuspa, S.H. & Poirier, M.C. (1988). Chemical carcinogenesis: from animal models to molecular models in one decade. Advances in Cancer Research 50, 25-70.
9. Barrett, J.C., Kakanuga, T., Kuroki, T., Neubert, D., Trosko, J.E., Vasilieu, J.M., Williams, G.M. & Yamasaki, H. (1986). Mammalian cell transformation in culture. In Long and Short Term Test Assays for Carcinogens: A Critical Appraisal. IARC Scientific Publication No. 83 (ed. R. Monsanto, H. Bartsch, H. Vainio, J. Wilbourn & H. Yamasaki), pp. 267-286. Lyon, France: IARC.
10. LeBoeuf, R.A., Kerckaert, G.A., Aardema, M.J., Gibson, D.P., Brauninger, R. & Isfort, R.J. (1996). The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutation Research 356, 85-127.
11. Landolph, J.R. (1985). Chemical transformation in C3H10T1/2 CC118 mouse embryo fibroblasts: historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol. In Transformation Assay of Established Cell Lines: Mechanisms and Application, IARC Scientific Publications No. 67 (ed. T. Kakunaga & H. Yamasaki), pp. 185-203. Lyon. France: IARC.
12. LeBoeuf, R.A., Kerckaert, K.A., Aardema, M.J. & Isfort, R.J. (1999). Use of Syrian hamster embryo and Balb/c 3T3 cell transformation for assessing the carcinogenicity potential of chemicals. In The Use of Short-and Medium-term Tests for Carcinogenic Hazard Evaluation. IARC Scientific Publications No. 146 (ed. D.B. McGregor, J.M. Rice & S. Venitt), pp. 409-425. Lyon, France: IARC.
13. Heidelberger, C., Freeman, A.E., Pienta, R.J., Sivak, A., Bertram, J.S., Casto, B.C., Dunkel, V.C., Francis, M.W., Kakunaga, T., Little, J.B. & Schechtman, L.M. (1983). Cell transformation by chemical agents - a review and analysis of the literature. A report of the US Environmental Protection Agency Gene-Tox Program. Mutation Research 114, 283-385.
14. Müller, L., Miltenburger, H.G., Marquardt, H. & Madle, S. (1993). The significance of in vitro cell transformation assays for routine testing. In Current Issues in Genetic Toxicology, pp. 102-113. Munich, Germany: Medizin-Verlag.
15. Sugimura, T., Terada, M., Yokota, J., Hirohashi, S. & Wakabayashi, K. (1992). Multiple genetic alterations in human carcinogenesis. Environmental Health Perspectives 98, 5-12.
16. Landolph, J.R., Dews, P.M., Ozbun, L. & Evans, D.P. (1996). Metal-induced gene expression and neoplastic transformation. In Toxicology of Metals (ed. L. Magos & T. Suzuki), pp. 321-329. Boca Raton, FL, USA: CRC Press.
17. Fusenig, N.E. & Boukamp, P. (1994). Carcinogenesis studies of human cells: reliable in vitro methods. In Cell Culture in Pharmaceutical Research (ed. N.E. Fusenig & H. Graf), pp. 79-102. Berlin, Germany: Springer.
18. Swierenga, S.H.H. & Yamasaki, H. (1992). Performance of tests for cell transformation and gap-junctional intercellular communication for detecting non-genotoxic carcinogenic activity. In Mechanisms of Carcinogenesis in Risk Identification. IARC Scientific Publications No. 116 (ed. H. Vainio, P.N. McGee, D.B. McGregor & A.J. McMichael), pp. 165-193. Lyon, France: IARC.
19. Isfort, R.J. & LeBoeuf, R.A. (1995). The Syrian hamster embryo (SHE) cell transformation system: a biologically relevant in vitro model - with carcinogen predicting capabilities - of in vivo multistage neoplastic transformation. Critical Reviews in Oncogenesis 6, 251-260.
20. Isfort, R.J. & LeBoeuf, R.A. (1996). Application of in vitro cell transformation assays to predict the carcinogenic potential of chemicals. Mutation Research 365, 161-173.
21. McGregor, D.B., Rice, J.M. & Venitt, S., eds (1999): Consensus report. In The Use of Short-and Medium-term Tests for Carcinogenic Hazard Evaluation. IARC Scientific Publications No. 146, pp. 1-18. Lyons, France: IARC.
22. Di Paolo, J.A. (1980). Quantitative in vitro transformation of Syrian golden hamster embryo cells with the use of frozen stored cells. Journal of the National Cancer Institutes 64, 1485-1489.
23. Lubet, R.A., Nims, R.W., Kiss, E., Kouri, R.E., Putman, D.L. & Schechtman, L.M. (1986). Influence of various parameters on benzo[a]pyrene enhancement of adenovirus SA7 transformation of Syrian hamster embryo cells. Environmental Mutagenesis 8, 533-542.
24. Pienta, R.J., Poiley, J.A. & Lebherz, W.B. (1977). Morphological transformation of early passage golden Syrian hamster embryo cells derived from cryopreserved primary cultures as a reliable in vitro assay for identifying diverse carcinogens. International Journal of Cancer 19, 642-655.
25. Kakunaga, T. (1973). A quantitative system for assay of malignant transformation by chemical carcinogens using a clone derived from Balb 3T3. International Journal of Cancer 12, 463-473.
26. Reznikoff, C.A., Bertram, J.S., Brankow, D.W. & Heidelberger, C. (1973). Quantitative and qualitative studies on chemical transformation of cloned C3H mouse embryo cells, sensitive to post-confluence inhibition of cell division. Cancer Research 33, 3239-3249.
27. Tsutsui, T., Hayashi, N., Maizumi, H., Huff, J. & Barrett, J.C. (1997). Benzene-, catechol-, hydroquinone-and phenol-induced cell transformation, gene mutations, chromosome aberrations, aneuploidy, sister-chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells. Mutation Research 373, 113-123.
28. Fritzenschaf, H., Kohlpoth, M., Rusche, B. & Schiffmann, D. (1993). Testing of known carcinogens and noncarcinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro: correlations with in vivo micronucleus formation and cell transformation. Mutation Research 319, 47-53.
29. Shuin, T., Billings, P.C., Lillehaug, J.R., Patierno, S., Roy-Burman, P. & Landolph, J.R. (1986). Enhanced expression of c-myc and decreased expression of c-fos proto-oncogenes in chemically and radiation-transformed C3H10T1/2 Cl 8 mouse embryo cell lines. Cancer Research 46, 5302-5311.
30. Schechtman, L.M. (1985). Balb/c 3T3 cell transformation: protocols, problems and improvements. In Transformation Assay of Established Cell Lines: Mechanisms and Application. IARC Scientific Publications No. 67 (ed. T. Kakunaga & H. Yamasaki), pp. 165-184. Lyon, France: IARC.
31. Kakunaga, T. & Yamasaki, H. (1985). Experimental protocols by the working group. In Transformation Assay of Established Cell Lines: Mechanisms and Application. IARC Scientific Publications No. 67 (ed. T. Kakunaga & H. Yamasaki), pp. 207-219. Lyon, France: IARC.
32. Dunkel, V.C., Rogers, C., Swierenga, S.H.H., Brillinger, R.L., Gilman, J.P.W. & Nestman, E.R. (1991). Recommended protocols based on a survey of current practice in genotoxicity testing laboratories. III. Cell transformation in C3H10T1/2 mouse embryo cell, Balb/c 3T3 mouse fibroblast and Syrian hamster embryo cell cultures. Mutation Research 246, 285-300.
33. Matthews, E.J. (1993). Transformation of Balb/c 3T3 cells. I. Investigation of experimental parameters that influence detection of spontaneous transformation. Environmental Health Perspectives 101, Suppl. 2, 277-291.
34. Matthews, E.J. (1993). Transformation of Balb/c 3T3 cells. II. Investigation of experimental parameters that influence detection of benzo[a]pyrene-induced transformation. Environmental Health Perspectives 101, Suppl. 2, 293-310.
35. Matthews, E.J. (1993). Transformation of Balb/c 3T3 cells. III. Development of a co-culture clonal survival assay for quantification of chemical cytotoxicity in high-density cell cultures. Environmental Health Perspectives 101, Suppl. 2, 311-318.
36. Tsuchiya, T. & Umeda, M. (1995). Improvement in the efficiency of the in vitro transformation assay method using Balb/3T3 A31-1-1 cells. Carcinogenesis 8, 1887-1894.
37. Aardema, M.J., Isfort, R.J., Thompson, E.D. & LeBoeuf, R.A. (1996). The low pH Syrian hamster embryo (SHE) cell transformation assay: a revitalized role in carcinogen prediction. Mutation Research 356, 5-9.
38. Kerckaert, G.A., Isfort, R.J., Carr, G.J., Aardema, M.J. & LeBoeuf, R.A. (1996). A comprehensive protocol for conducting the Syrian hamster embryo cell transformation assay at pH 6.70. Mutation Research 356, 65-84.
39. Yamasaki, H., Enomoto, T., Shiba, Y., Kanno, Y. & Kakunaga, T. (1985). Intercellular communication capacity as a possible determinant of transformation sensitivity of Balb/c 3T3 clonal cells. Cancer Research 45, 637-641.
40. Tsuchiya, T. & Umeda, M. (1997). Relationship between exposure to TPA and appearance of transformed cells in MNNG-initiated transformation of Balb/c 3T3 cells. International Journal of Cancer 73, 271-276.
41. Billings, P.C., Heidelberger, C. & Landolph, J.R. (1985). S-9 metabolic activation enhances aflatoxin-mediated transformation of C3H10T1/2 cells. Toxicology and Applied Pharmacology 77, 58-65.
42. Schechtman, L.M., Kiss, F., McCarvill, J., Gallagher, M., Kouri, R.E. & Lubet, R.A. (1982). A method for amplification of sensitivity of the C3H10T1/2 cell transformation assay. Proceedings of the American Association for Cancer Research 23, 74.
43. Miura, T., Patierno, S.R., Sakuramoto, T. & Landolph, J.R. (1989). Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environmental and Molecular Mutagenesis 14, 65-78.
44. Patierno, S.R., Banh, D. & Landolph, J.R. (1988). Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Research 48, 5280-5288.
45. Pienta, R.J. (1979). A hamster model system for identifying carcinogens. In Carcinogens: Identification and Mechanism of Action (ed. A.C. Griffin & C.R. Shaw), pp. 121-141. New York, USA: Raven Press.
46. Rivedal, E. & Haddeland, U. (1996). Role of serum in the morphological transformation of Syrian hamster embryo cells. Characterisation and partial purification of protein factors in fetal bovine serum. Toxicology in Vitro 10, 217-227.
47. Kuroki, T. & Sasaki, K. (1985). Relationship between in vitro cell transformation and in vivo carcinogenesis based on available data on the effects of chemicals. In Transformation Assay of Established Cell Lines: Mechanisms and Application. IARC Scientific Publications No. 67 (ed. T. Kakunaga & H. Yamasaki), pp. 93-118. Lyon, France: IARC.
48. McGregor, D. & Ashby, J. (1985). Summary report on the performance of the cell transformation assays. In Progress in Mutation Research, Vol. 5, Evaluation of Short-term Tests for Carcinogens (ed. J. Ashby, F.J. de Serres, M. Draper, M. Ishidate, Jr, B.H. Margolin, B.E. Matter & M.D. Shelby), pp. 103-115. Amsterdam, The Netherlands: Elsevier Science.
49. Isfort, R.J., Cody, D.B., Kerckaert, G.A., Tycko, B. & LeBoeuf, R.A. (1997). Role of the H19 gene in Syrian hamster embryo cell tumorigenicity. Molecular Carcinogenesis 20, 189-193.
50. Bertolero, F., Pozzi, G., Sabbioni, E. & Saffiotti, U. (1987). Cellular uptake and metabolic reduction of pentavalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis 8, 803-808.
51. Sabbioni, E., Pozzi, G., Pintar, A., Casella, L. & Garattini, S. (1991). Cellular retention, cytotoxicity and morphological transformation by vanadium (IV) in Balb/3T3 cell line. Carcinogenesis 12, 47-52.
52. Sabbioni, E., Fischbach, M., Pozzi, G., Pietra, R., Gallorini, M. & Piette, J.L. (1991). Cellular retention, toxicity and carcinogenic potential of seafood arsenic. I. Lack of cytotoxicity and transforming activity of arsenobetaine in the Balb/3T3 cell line. Carcinogenesis 12, 1287-1291.
53. Sabbioni, E. & Balls, M. (1995). Use of cell culture and nuclear and radioanalytical techniques for environmental, occupational and biomedical metal toxicology research at the JRC-Ispra. In Alternative Methods in Toxicology and the Life Sciences, Vol. 11, The World Congress on Alternatives and Animal Use in the Life Sciences: Education, Research, Testing (ed. A.M. Goldberg & L.F.M. van Zutphen), pp. 101-108. New York, USA: Mary Ann Liebert.
54. Matthews, E.J., Spalding, J.W. & Tennant, R.W. (1993). Transformation of BALB/c 3T3 cells. IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure. Environmental Health Perspectives 101, 347-482.
55. Matthews, E.J., Spalding, J.W, & Tennant, R.W. (1993). Transformation of BALB/c 3T3 cells. V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays. Environmental Health Perspectives 101, 347-482.
56. IARC (1987). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 6. Genetic and Related Effects: An Updating of Selected IARC Monographs from Volumes 1 to 42, 729pp. Lyon, France: IARC.
57. McCormick, J.J. & Maher, V.M. (1989). Malignant transformation of mammalian cells in culture, including human cells. Environmental and Molecular Mutagenesis 14, 105-113.
58. McCormick, J.J. & Maher, V.M. (1994). Analysis of the multistep process of carcinogenesis using human fibroblasts. Risk Analysis 14, 257-263.
59. O'Reilly, S., Walicka, M., Kohler, S.K., Dunstan, R., Maher, V.M. & McCormick, J.J. (1998). Dose-dependent transformation of cells of human fibroblast cell strain MSU-1.1 by cobalt-60 gamma radiation and characterisation of the transformed cells. Radiation Research 150, 577-584.
60. Boukamp, P., Dzarlieva-Petrusevska, R.T., Breitkreutz, D., Hornung, J., Markham, A. & Fusenig, N.E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. Journal of Cell Biology 106, 761-771.
61. Boukamp, P., Popp, S., Altmeyer, S., Hülsen, A., Fasching, C., Cremer, T. & Fusenig, N.E. (1997). Sustained non-tumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte cell line HaCaT. Genes Chromosomes and Cancer 19, 201-214.
62. Breitkreutz, D., Schoop, V.M., Mirancea, N., Baur, M., Stark, H-J. & Fusenig, N.E. (1998). Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. European Journal of Cell Biology 75, 273-286.
63. Boukamp, P., Peter, W., Pascheberg, U., Altmeier, S., Fasching, C., Stanbridge, E.J. & Fusenig, N.E. (1995). Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, ras-H oncogene activation and additional chromosome loss. Oncogene 11, 961-969.
64. Fusenig, N.E. & Boukamp, P. (1998). Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocyes. Molecular Carcinogenesis 23, 144-158.
65. Bleuel, K., Popp, S., Fusenig, N.E., Stanbridge, E.J. & Boukamp, P. (1999). Tumor suppression in human skin carcinoma cells induced by chromosome 15 transfer of TSP-1 overexpression is caused by halting tumor vascularization. Proceedings of the National Academv of Sciences, USA 96, 2065-2070.
66. Schoop, V., Mirancea, N. & Fusenig, N.E. (1999). Epidermal organization and differentiation of HaCaT keratinocytes in organotypic co-culture with human dermal fibroblasts. Journal of Investigative Dermatology 112, 343-353.
67. Morgan, T.L., Yang, D., Fry, D.G., Hurlin, P.J., Kohler, S.K., Maher, V.M. & McCormick, J.J. (1991). Characteristics of an infinite life span diploid human fibroblast cell strain and a neardiploid strain arising from a clone of cells expressing a transfected v-myc oncogene. Environmental Cell Research 197, 125-136.
68. Hurlin, P.J., Maher, V.M. & McCormick, J.J (1989). Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene. Proceedings of the National Academy of Sciences, USA 86, 187-191.
69. Yang, D., Louden, C., Reinhold, D.S., Kohler, S.K., Maher, V.M. & McCormick, J.J. (1992). Malignant transformation of human fibroblast cells strain MSU-1.1 by (+/-)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene. Proceedings of the National Acadamy of Sciences, USA 89, 3237-3241.
70. Reinhold, D.S., Walicka, M., Elkassaby, M., Milam, L.D., Kohler, S.K., Dunstan, R.W. & McCormick, J.J. (1996). Malignant transformation of human fibroblasts by ionising radiation. International Journal of Radiation Biology 69, 707-715.
71. INK4a expression in tumorgenic fibroblastic cell lines derived from MSU-1.1 cells. Proceedings of the American Association for Cancer Research 40, 684.
72. Aust, A.E., Falahee, K.J., Maher, V.M. & McCormick, J.J. (1980). Human cell-mediated benzo[a]pyrene cytotoxicity and mutagenicity in human diploid fibroblasts. Cancer Research 40, 4070-4075.
73. Stuard, S.B., Kerckaert, G.A. & Lehman-McKeeman, L.D. (1999). Characterisation of the metabolic capacity of Syrian hamster embryo (SHE) cells. Toxicological Sciences 48, 366.
74. Steele, V.E., Sharma, S., Mehta, R., Elmore, E., Redpath, J.L., Rudd, C., Bagheri, D., Sigman, C.C. & Kelloff, G.J. (1996). Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. Journal of Cellular Biochemistry 265, 29-53.
75. Ridder, G.M., Stuard, S.B, Kerckaert, G.A., Cody, D.B., LeBoeuf, R.A. & Isfort, R.J. (1997). Computerized image analysis of morphologically transformed and nontransformed Syrian hamster embryo (SHE) cell colonies: application to objective SHE cell transformation assay scoring. Carcinogenesis 18, 1965-1972.
76. Gatehouse, D.G. (1994). Mutagenicity. In International Pharmaceutical Product Registration -Aspects of Quality, Safety and Efficacy (ed. A.C. Cartwright & B.R. Mathews), pp. 474-552. New York, USA: Ellis Horwood.
77. ICH (1999). ICH Guidance S1B: Testing for Carcinogenicity of Pharmaceuticals. Note 1. Web site http://www.ifpma.org/ichl.html.
78. Federal Register (1998). Federal Register February 23, Vol. 63, No. 35.
79. ICH (1998). Genotoxicity: a standard battery of genotoxicity testing of pharmaceuticals. In The Proceedings of the Fourth International Conference on Harmonization (ed P.F. D'Arcy & D.W.G Harron), pp. 987-998. Antrim, UK: Greystone Books.
80. FDA (1993). Food and Drug Administration Draft: Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food. Washington, DC: US Food and Drug Administration Centre for Food Safety and Applied Nutrition.
81. Yamasaki, H., Ashby, J., Bignami, M., Jongen, W., Linnainmaa, K., Newbold, R.F., Bguyen-Ba, G., Parodi, S., Rivedal, E., Schiffmann, D., Simons, J.W.I.M. & Vasseur, P. (1996). Nongenotoxic carcinogens: development of detection methods based on mechanisms. Mutation Research 353, 47-63.
82. Müller, L. & Kasper, P. (1999). Human biological relevance and the use of threshold arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. Mutation Research, in press.
83. Blaauboer, B.J., Bayliss, M.K., Castell, J.V., Evelo, C.T.A., Frazier, J.M., Groen, K., Gülden, M., Guillouzo, A., Hissink, A.M., Houston, J.B., Johanson, G., de Jongh, J., Kedderis, G.L., Reinhardt, C.A., van de Sandt, J.J.M. & Semino, G. (1996). The use of biokinetics and in vitro methods in toxicological risk evaluation. The report and recommendations of ECVAM workshop 15. ATLA 24, 473-497.
84. Kerckaert, G.A., LeBoeuf, R.A. & Isfort, R.J. (1998). Assessing the predictiveness of the Syrian hamster embryo cell transformation assay for determining rodent carcinogenic potential of single ring aromatic/nitroaromatic amine compounds. Toxicological Sciences 41, 189-197.
85. ICH (1999). ICH Guidance S2B: A Standard Battery for Genotoxicity Testing of Pharmaceuticals. Web site http://www.ifpma.org/ichl.html.
86. Müller, K., Kasper, P., Thiele, N., Henke, M., Madle, S. & Müller, L. (1990). A critical comment on the SHE cell transformation assay. Mutagenesis 5, 628-629.
87. Balls, M. (1998). Why is it proving to be so difficult to replace animal tests? Laboratory Animals 27, 44-47.